hydroxyethylamine transition-state inhibitor 1   Click here for help

GtoPdb Ligand ID: 8688

PDB Ligand
Compound class: Synthetic organic
Comment: A hydroxyethylamine transition-state mimetic inhibitor of BACE2 with a crystal structure. This compound was initially identified as a BACE1 inhibitor by Novartis [2]. A series of analogues is specified in a Novartis patent but without activity data [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 3
Rotatable bonds 10
Topological polar surface area 70.59
Molecular weight 504.24
XLogP 6.01
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Cc1cccc(c1)CNCC(C(NC(=O)C1=Cc2ccccc2Oc2c1cccc2)Cc1ccccc1)O
Isomeric SMILES Cc1cccc(c1)CNC[C@H]([C@@H](NC(=O)C1=Cc2ccccc2Oc2c1cccc2)Cc1ccccc1)O
InChI InChI=1S/C33H32N2O3/c1-23-10-9-13-25(18-23)21-34-22-30(36)29(19-24-11-3-2-4-12-24)35-33(37)28-20-26-14-5-7-16-31(26)38-32-17-8-6-15-27(28)32/h2-18,20,29-30,34,36H,19,21-22H2,1H3,(H,35,37)/t29-,30+/m0/s1
InChI Key BNWZCXDHHPBQOX-XZWHSSHBSA-N
References
1. Auberson Y et al.. (2005)
Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof.
Patent number: WO2005014517. Assignee: Novartis. Priority date: 25/07/2003. Publication date: 03/11/2009.
2. Ostermann N, Eder J, Eidhoff U, Zink F, Hassiepen U, Worpenberg S, Maibaum J, Simic O, Hommel U, Gerhartz B. (2006)
Crystal structure of human BACE2 in complex with a hydroxyethylamine transition-state inhibitor.
J Mol Biol, 355 (2): 249-61. [PMID:16305800]